Australia's most trusted
source of pharma news
Sunday, 08 September 2024
Posted 30 November 2023 AM
CSL has landed its first regulatory approval for its new self-amplifying messenger RNA technology.
This week Japan's Ministry of Health, Labor and Welfare granted approval for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, for initial vaccination and booster for adults 18 years and older.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.